Immune Checkpoint Inhibitor and Radiotherapy-Related Pneumonitis: An Informatics Approach to Determine Real-World Incidence, Severity, Management, and Resource Implications.

Hindocha, Sumeet; Campbell, Des; Ahmed, Merina; Giorgakoudi, Kyriaki; Sharma, Bhupinder; Yousaf, Nadia; Molyneaux, Philip; Hunter, Benjamin; Kalsi, Hardeep; Cui, Wanyuan; Davidson, Michael; Bhosle, Jaishree; Minchom, Anna; Locke, Imogen; McDonald, Fiona; O'Brien, Mary; Popat, Sanjay; Lee, Richard W

Hindocha, Sumeet; Campbell, Des; Ahmed, Merina; Giorgakoudi, Kyriaki; Sharma, Bhupinder; Yousaf, Nadia; Molyneaux, Philip; Hunter, Benjamin; Kalsi, Hardeep; Cui, Wanyuan; Davidson, Michael; Bhosle, Jaishree; Minchom, Anna; Locke, Imogen; McDonald, Fiona; O'Brien, Mary; Popat, Sanjay; Lee, Richard W.

Afiliação

Hindocha S; Lung Unit, The Royal Marsden, National Health Service (NHS) Foundation Trust, London, United Kingdom.
Campbell D; Artificial Intelligence (AI) for Healthcare Centre for Doctoral Training, Imperial CollegeLondon, London, United Kingdom.
Ahmed M; Early Diagnosis and Detection, The National Institute for Health Research (NIHR) Biomedical Research Centre at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, United Kingdom.
Giorgakoudi K; Performance & Information Department, The Royal Marsden, National Health Service (NHS) Foundation Trust, London, United Kingdom.
Sharma B; Lung Unit, The Royal Marsden, National Health Service (NHS) Foundation Trust, London, United Kingdom.
Yousaf N; Early Diagnosis and Detection, The National Institute for Health Research (NIHR) Biomedical Research Centre at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, United Kingdom.
Molyneaux P; School of Health Sciences, City University of London, London, United Kingdom.
Hunter B; Radiology Department, The Royal Marsden, National Health Service (NHS) Foundation Trust, London, United Kingdom.
Kalsi H; Lung Unit, The Royal Marsden, National Health Service (NHS) Foundation Trust, London, United Kingdom.
Cui W; Fibrosis Research Group, Inflammation, Repair and Development Section, National Heart and Lung Institute, Imperial College London, London, United Kingdom.
Davidson M; Lung Unit, The Royal Marsden, National Health Service (NHS) Foundation Trust, London, United Kingdom.
Bhosle J; Early Diagnosis and Detection, The National Institute for Health Research (NIHR) Biomedical Research Centre at The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, United Kingdom.
Minchom A; Lung Unit, The Royal Marsden, National Health Service (NHS) Foundation Trust, London, United Kingdom.
Locke I; Lung Unit, The Royal Marsden, National Health Service (NHS) Foundation Trust, London, United Kingdom.
McDonald F; Lung Unit, The Royal Marsden, National Health Service (NHS) Foundation Trust, Sutton, United Kingdom.
O'Brien M; Lung Unit, The Royal Marsden, National Health Service (NHS) Foundation Trust, Sutton, United Kingdom.
Popat S; Lung Unit, The Royal Marsden, National Health Service (NHS) Foundation Trust, Sutton, United Kingdom.
Lee RW; Lung Unit, The Royal Marsden, National Health Service (NHS) Foundation Trust, London, United Kingdom.

Front Med (Lausanne) ; 8: 764563, 2021.

Article em En | MEDLINE | ID: mdl-34790682

Palavras-chave

checkpoint inhibitor; health economics; immunotherapy; informatics; pneumonitis; radiotherapy

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Temas: ECOS / Aspectos_gerais / Gestao Bases de dados: MEDLINE Tipo de estudo: Incidence_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Med (Lausanne) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google